Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-30 · accession 0000899243-23-010140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-31 | 2023-03-31 | BEAM | Bellon Christine | CLO | A - Grant | $0.00 | +17.5K | 84.9K | +26% | $0 |
| DM | 2023-03-31 | 2023-03-30 | BEAM | Bellon Christine | CLO | M - OptEx | $7.22 | +8,941 | 67.4K | +15% | +$64.6K |
| DM | 2023-03-31 | 2023-03-30 | BEAM | Bellon Christine | CLO | M - OptEx | $0.00 | -8,941 | 16.7K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | A | A | 17,500 | $0.00 | 84,882 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date. |
| 2 | Common | Common Stock | 2023-03-30 | M | A | 6,272 | $7.22 | 64,713 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-30 | M | A | 2,669 | $7.22 | 67,382 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-03-30 | M | D | 6,272 | $0.00 | 13,674 | D | $7.22 · — to 2029-05-16 | 6,272 Common Stock | (F2) This stock option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-03-30 | M | D | 2,669 | $0.00 | 16,736 | D | $7.22 · — to 2029-05-17 | 2,669 Common Stock | (F3) This stock option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested. |